Lower riskDrug recall · FDA · Published June 16, 2026
Harvard Drug Group Recalls Methylergonovine Tablets Due to Subpotent Drug Risk
Harvard Drug Group recalls methylergonovine maleate tablets (0.2 mg) with subpotent drug risk. Affected lots expire 09/2026 to 08/2027. Consumers should contact the manufacturer for details.
“Harvard Drug Group Recalls Methylergonovine Tablets Due to Subpotent Drug Risk.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/31196-harvard-drug-group-recalls-methylergonovine-tablets-due-to-subpotent-drug. Based on FDA recall #D-0609-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0609-2026%22&limit=1).
The Food and Drug Administration announced on June 16, 2026, that The Harvard Drug Group LLC is recalling Methylergonovine Maleate Tablets due to subpotent drug risks. Owners should contact the company for a refund.
The recall is classified as Class II because the Methylergonovine Maleate Tablets are subpotent, meaning they may not contain the labeled amount of active ingredient. The FDA stated that this defect could result in inadequate treatment for the condition for which the drug is prescribed.
Context
GovInfoNow's records show The Harvard Drug Group, LLC has issued seven other recalls since December 31, 2014. Recent brand recalls include a March 24, 2026, recall of Memantine Capsules for failed dissolution specifications and an April 9, 2026, recall of Omega-3 Capsules due to failed capsule specifications. Other recent recalls of similar products include the May 29, 2026, Gasco Isopropyl Alcohol 70% recall for subpotent drug risk and the July 13, 2026, Major Pharmaceuticals Levothyroxine Tablets recall for subpotent drug risk.
How to tell if you have this one
Check the blister label for the product name 'Methylergonovine Maleate Tablets, 0.2 mg, USP'. Look for lot numbers N02327 (expires 09/2026), N02740 (expires 12/2026), or N03069 (expires 08/2027).
Brand
The Harvard Drug Group
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Identify the lot number on the blister label to confirm if your tablets are in the recalled lots.
Contact Manufacturer
Reach out to Harvard Drug Group for specific instructions on what to do with the recalled tablets.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “U.S. Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 15 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0609-2026 (June 16, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0609-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.